INFINITY PHARMACEUTICALS INC (INFI) Stock Analyst Earnings Estimates
NASDAQ:INFI - Nasdaq - US45665G3039 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.7M -43.33% | 1.858M 9.29% | 2.593M 39.56% | 2.754M 6.21% | 3.57M 29.63% | -100.00% | 18.36M | 56.1M 205.56% | 86.7M 54.55% | 121.38M 40.00% | 154.02M 26.89% | |
| EBITDA YoY % growth | -38M 16.48% | -44.603M -17.38% | -44.386M 0.49% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -38.5M 15.75% | -45.083M -17.10% | -44.844M 0.53% | -48.923M -9.10% | -43.152M 11.80% | -42.84M 0.72% | -23.46M 45.24% | 7.14M 130.43% | 31.62M 342.86% | 57.12M 80.65% | 78.54M 37.50% | |
| Operating Margin | -2,264.71% | -2,426.43% | -1,729.43% | -1,776.44% | -1,208.73% | N/A | -127.78% | 12.73% | 36.47% | 47.06% | 50.99% | |
| EPS YoY % growth | -0.67 18.29% | -0.53 20.90% | -0.50 5.66% | -0.47 6.16% | -0.56 -19.57% | -0.29 49.09% | N/A | N/A | N/A | N/A | N/A |
All data in USD
| Q3 / 23 | Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.12 -2.00% | -0.12 -11.27% | -0.13 -10.50% | -0.13 -8.33% | -0.14 -16.67% | -0.15 -25.00% |
| Revenue Q2Q % growth | 714K 0.28% | 765K 40.88% | 816K 11.63% | 918K 57.46% | 918K 28.57% | 1.02M 33.33% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -10.681M 1.83% | -11.426M -19.79% | -11.406M 0.88% | -12.151M -20.07% | -12.641M -18.34% | -13.385M -17.15% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 5.85% | -0.12 | % | |
| Q1 2023 Q2Q % growth | -0.12 14.29% | -0.11 | -0.01 | -12.04% |
| Q4 2022 Q2Q % growth | -0.11 15.38% | -0.03 | -0.08 | -223.56% |
| Q3 2022 Q2Q % growth | -0.12 | -0.06 | -0.06 | -96.08% |
| Q2 2022 Q2Q % growth | -0.13 | -0.15 | 0.02 | 12.70% |
| Q1 2022 Q2Q % growth | -0.14 6.67% | -0.14 | 0.00 | -1.67% |
| Q4 2021 Q2Q % growth | -0.13 18.75% | -0.14 | 0.01 | 5.59% |
| Q3 2021 Q2Q % growth | -0.12 25.00% | -0.14 | 0.02 | 12.53% |
| Q2 2021 Q2Q % growth | -0.13 18.75% | -0.14 | 0.01 | 6.29% |
| Q1 2021 Q2Q % growth | -0.15 21.05% | -0.13 | -0.02 | -17.81% |
| Q4 2020 Q2Q % growth | -0.16 20.00% | -0.16 | 0.00 | -0.12% |
| Q3 2020 Q2Q % growth | -0.16 20.00% | -0.16 | 0.00 | -0.55% |
| Q2 2020 Q2Q % growth | -0.16 11.11% | -0.19 | 0.03 | 17.70% |
| Q1 2020 Q2Q % growth | -0.19 20.83% | -0.13 | -0.06 | -40.90% |
| Q4 2019 Q2Q % growth | -0.20 | -0.19 | -0.01 | -2.66% |
| Q3 2019 Q2Q % growth | -0.20 | -0.10 | -0.10 | -105.32% |
| Q2 2019 Q2Q % growth | -0.18 | -0.07 | -0.11 | -168.40% |
| Q1 2019 Q2Q % growth | -0.24 | -0.05 | -0.19 | -404.17% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 583K -15.01% | 714K | -131K | -18.35% |
| Q1 2023 Q2Q % growth | 731K 12.12% | 306K | 425K | 138.89% |
| Q4 2022 Q2Q % growth | 543K 20.40% | 612K | -69K | -11.27% |
| Q3 2022 Q2Q % growth | 712K 66.36% | 6.312M | -5.6M | -88.72% |
| Q2 2022 Q2Q % growth | 686K 33.98% | 528.36K | 157.64K | 29.84% |
| Q1 2022 Q2Q % growth | 652K 30.40% | 352.073K | 299.927K | 85.19% |
| Q4 2021 Q2Q % growth | 451K 12.75% | 307.53K | 143.47K | 46.65% |
| Q3 2021 Q2Q % growth | 428K -14.40% | 534.143K | -106.143K | -19.87% |
| Q2 2021 Q2Q % growth | 512K 28.00% | 284.917K | 227.083K | 79.70% |
| Q1 2021 Q2Q % growth | 500K 25.00% | 1.171M | -671K | -57.30% |
| Q4 2020 Q2Q % growth | 400K 33.33% | 281.347K | 118.653K | 42.17% |
| Q3 2020 Q2Q % growth | 500K 66.67% | 168.3K | 331.7K | 197.09% |
| Q2 2020 Q2Q % growth | 400K 33.33% | 163.812K | 236.188K | 144.18% |
| Q1 2020 Q2Q % growth | 400K -80.95% | 161.772K | 238.228K | 147.26% |
| Q4 2019 Q2Q % growth | 300K | 161.16K | 138.84K | 86.15% |
| Q3 2019 Q2Q % growth | 300K | 7.548M | -7.248M | -96.03% |
| Q2 2019 Q2Q % growth | 300K | 8.568M | -8.268M | -96.50% |
| Q1 2019 Q2Q % growth | 2.1M | 6.8M | -4.7M | -69.12% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 4% | 0% | 5.15% |
| Revenue | 0% | 100% | 0% | 100% |